menu
    • menu

    Company profile for Altamira Therapeutics

    NEW Drugs in Dev: 7
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We at Auris Medical are dedicated to developing novel pharmaceutical products for the treatment of inner ear disorders and central nervous system disorders. We are focusing on the development of intranasal betahistine for the treatment of vertigo (AM-125) and for the prevention of antipsychotic-induced weight gain and somnolence (AM-201). These programs have gone through two Phase 1 trials and will move into proof-of-concept s...
    We at Auris Medical are dedicated to developing novel pharmaceutical products for the treatment of inner ear disorders and central nervous system disorders. We are focusing on the development of intranasal betahistine for the treatment of vertigo (AM-125) and for the prevention of antipsychotic-induced weight gain and somnolence (AM-201). These programs have gone through two Phase 1 trials and will move into proof-of-concept studies in 2019. In addition, Auris Medical has two Phase 3 programs under development: Sonsuvi® (AM-111) for acute inner ear hearing loss and Keyzilen® (AM-101) for acute inner ear tinnitus.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Altamira TherapeuticsBermuda Flag
    Country
    Country
    Bermuda
    Address
    Address
    Clarendon House 2 Church Street Hamilton HM 11
    Telephone
    Telephone
    +41 61 201 13 50
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aurismedical.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/altamira-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Altamira Therapeutics To Present At mRNA Therapeutics Summit
    Altamira Therapeutics To Present At mRNA Therapeutics Summit

    23 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-23/altamira-therapeutics-to-present-at-mrna-based-therapeutics-summit

    PHARMIWEB
    23 Jan 2026
    Share Share
    Altamira Therapeutics Secures Swiss Market Approval for Bentrio
    Altamira Therapeutics Secures Swiss Market Approval for Bentrio

    19 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-19/altamira-therapeutics-announces-market-approval-of-bentrio-nasal-spray-in-china

    PHARMIWEB
    19 Dec 2025
    Share Share
    Altamira Therapeutics Announces Bentrio MDR Certification
    Altamira Therapeutics Announces Bentrio MDR Certification

    20 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-20/altamira-therapeutics-announces-certification-of-bentrio-nasal-spray-under-medical-device-regulation

    PHARMIWEB
    20 Nov 2025
    Share Share
    Altamira Pharma Achieves DNA Molecule Delivery Via Nanoparticles
    Altamira Pharma Achieves DNA Molecule Delivery Via Nanoparticles

    03 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-03/altamira-therapeutics-announces-successful-nanoparticle-based-delivery-of-dna-molecules

    PHARMIWEB
    03 Nov 2025
    Share Share
    Altamira Therapeutics Updates Business Progress and Reveals H1
    Altamira Therapeutics Updates Business Progress and Reveals H1

    29 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-29/altamira-therapeutics-provides-business-update-and-first-half-2025-financial-results

    PHARMAWEB
    29 Aug 2025
    Share Share
    Altamira Therapeutics to Host First Half 2025 Financial Results
    Altamira Therapeutics to Host First Half 2025 Financial Results

    26 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-26/altamira-therapeutics-to-host-first-half-2025-financial-results-and-business-update-call-on-august-2

    PHARMAWEB
    26 Aug 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search